Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Apceth GmbH und Co. KG
Apceth GmbH und Co. KG
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Donaldson's Isolere Bio launches IsoTag reagent for optimal AAV purification
The IsoTag AAV reagent can purify adeno associated viruses for research purposes, achieving up to an 85% in yield
Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA
The subcutaneous, self-administering prophylactic can allow a patient to produce thrombin, a clotting agent, even in the presence of inhibitors
groninger showcases filling and closing solutions for OTC pharma at Pack Expo
Discover the flexcare 101 and flexfill machines designed for enhanced efficiency and flexibility in pharmaceutical production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Ingredients
Refined commercial production spec gets gene therapy EMA go-ahead
US-based Bluebird Bio is working with German apceth Biopharma for commercial manufacturing of its one-time thalassemia therapy that is approved in the EU, not the US
Regulatory
Apceth bullish on manufacturing deal with bluebird bio
The German CDMO will operate as commercial manufacturer in Europe for Zynteglo, bluebird bio's first gene therapy to gain regulatory approval
Finance
Hitachi buys all Acpeth Biopharma shares
Apceth Biopharma now becomes Hitachi's new European hub for cell therapy
Manufacturing
apceth Biopharma Appoints Dusan Kosijer as Chief Financial Officer
Research & Development
apceth and University of Cologne join forces on immunotherapies for cancer
The collaboration is based on combinations of chimeric antigen receptor (CAR) T cells and apceth-developed engineered mesenchymal stem cells
Research & Development
Apceth expands senior management team
Ulrike Verzetnitsch joins the company as Chief Technical Officer
Research & Development
Apceth names Stefanos Theoharis as Chief Business Officer
He will lead Apceth’s business development
Subscribe now